Total Funding
58
54
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
72216
VisionGate offers an automated 3D cell imaging platform that saves lives through early cancer detection and prevention.
Randy Buness: CFO- Michael Meyer: Chief Technical Officer
About the Company
VisionGate is dedicated to saving lives through early cancer detection and prevention, utilizing its revolutionary automated 3D cell imaging platform that is capable of generating high-resolution 3D biosignatures from intact cells. It is a clinical-stage oncology pharmaceutical and diagnostics company.
Their lead diagnostic product is the LuCED
lung test - a non-invasive sputum-based test that detects abnormal cells which indicate lung cancer and bronchial dysplasia.
It was founded by Alan Nelson and is based in Phoenix, Arizona.
